
Chemical and Pharmaceutical Bulletin p. 782 - 786 (1998)
Update date:2022-07-30
Topics:
Martin-Martinez, Mercedes
Ballaz, Santiago
Latorre, Miriam
Herranz, Rosario
Garcia-Lopez, M. Teresa
Cenarruzabeitia, Edurne
Del Rio, Joaquin
Gonzalez-Muniz, Rosario
In order to find new classes of non-peptide cholecystokinin (CCK) ligands, the conformational restriction of a series of weak 3- oxoindolizidine-based CCK antagonists has been both decreased and increased. This tactic yielded a series of monocyclic 2-oxopyrrolidine derivatives 4 with selectivity for CCK-A or CCK-B receptors and with slightly improved binding affinity at the CCK-A receptor subtype with respect to the model 3- oxoindolizidines. In contrast, the incorporation of the Trp residue at the secondary amino group of a pyrrolo[1,2-a]pyrazine template 5, involving a drastic restriction in the conformational flexibility of the molecule, resulted in a series of bicyclic derivatives that did not bind to CCK receptors at concentrations up to 10-5 M.
View Morejiangsu haian chemical co.,ltd.
Contact:86-513-15851283853
Address:No.99,Changjiang West Road,Haian County,Jiangsu Province,China
Contact:+44 (0)2036089360-31
Address:Chanceryhouse,Chancery Lan
Contact:+86 21 5017 5386
Address:No 999,Jiangyue Rd, Minhang Dist ,201114,Shanghai ,China
Contact:86-021-52418058
Address:8/F, Building 6, Guiping Road No.333, Shanghai, 200233, China
Fujian Wanke Pharmaceutical Co., LTD.
Contact:+86-598-5026002
Address:Economic development zone,jiangle county
Doi:10.1080/00958972.2010.548862
(2011)Doi:10.1039/c0cc04677a
(2011)Doi:10.1021/jo980541v
(1998)Doi:10.1021/acschemneuro.6b00181
(2017)Doi:10.1016/j.jorganchem.2016.12.013
(2017)Doi:10.1021/jm000286i
(2000)